SRx Health Solutions (SRXH)
XASE:SRXH
Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$0.24
--
Market closed
$0.24
--
Day’s Range― - ―
52-Week Range$0.08 - $1.92
Previous CloseN/A
VolumeN/A
Average Volume (3M)695.52K
Market Cap
$33.97M
Enterprise Value$11.88M
Total Cash (Recent Filing)$13.06M
Total Debt (Recent Filing)$21.03M
Price to Earnings (P/E)―
Beta0.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding298,207,670
10 Day Avg. Volume504,141
30 Day Avg. Volume695,518
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)16.44
Price to Sales (P/S)1.02
P/FCF Ratio-0.61
Enterprise Value/Market Cap0.35
Enterprise Value/Revenue-0.90
Enterprise Value/Gross Profit-4.50
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialty Pharmacy & Patient SupportSRx’s core operations center on specialty pharmacy and patient-support services, a durable revenue base linked to complex therapy dispensing and manufacturer service contracts. These services benefit from structural growth in specialty drugs and recurring service fees that support predictable demand over months.
Redeemed Series A Preferred; Simplified CapitalThe redemption removed a layered preferred instrument and eliminated large potential common dilution, simplifying the capital structure. That enhances long-term financial flexibility, reduces contingent claims, and makes future equity or strategic deals easier to execute without complex conversion overhangs.
EMJ Merger & Form S-4 Filed To Add Treasury CapabilityProgress toward combining with EMJ Crypto and filing an S-4 signals a structural shift to institutionalize digital-asset treasury management. If completed, the merger could diversify non-operating income sources and institutionalize a rules-based treasury that improves long-term cash returns and risk management.
Bears Say
High Leverage & Thin EquityExtremely elevated leverage and a historically thin or negative equity base materially constrain financial flexibility. High debt levels increase refinancing and interest risks, limit capacity for investment in core operations, and raise the probability that weak operating results will trigger covenant or solvency stress over months.
Persistent Cash BurnNegative operating and free cash flow in recent periods indicate the business is not self-financing its operations. Continued cash burn forces reliance on external financing, increasing dilution or debt, and elevates execution risk for operational initiatives over the next several months if profitability and cash conversion are not restored.
NYSE Listing Compliance WarningA public NYSE warning highlights governance and process-control deficiencies with potential regulatory consequences. Continued noncompliance could lead to delisting risk, reduced investor confidence, and added compliance costs, which materially impair strategic options and access to capital over the medium term.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.08 and its highest was $1.92 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $33.97M.
When is SRx Health Solutions’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SRx Health Solutions’s earnings last quarter?
Currently, no data Available
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions does not currently pay dividends.
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 298,207,670 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SRx Health Solutions Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.7%
Last 30 Days ▲ 12.2%
Last 30 Days ▲ 12.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.80%
12-Months-Change
Fundamentals
Return on Equity
435.85%
Trailing 12-Months
Asset Growth
76.96%
Trailing 12-Months
Company Description
SRx Health Solutions
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
0.55% Insiders
0.09% Mutual Funds
0.02% Other Institutional Investors
99.35% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---